Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550366 · ClinicalTrials.gov registry record
Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI
A clinical trial, sponsored by University of Minnesota.
- Terminated
- Registry status
- 44
- Enrollment target
NCT02550366 is a clinical trial that was terminated before completion, run by University of Minnesota. The registered enrollment target is 44 participants.
The verdict
NCT02550366 was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- 44 participants
- Enrollment target
Study Summary
Coronary artery disease (CAD) is the leading cause of death in the United States. Cardiac MRI is a non-invasive non-ionizing technique for a comprehensive cardiac exam, which can be used in the diagnosis of CAD. In this work, the investigators will develop and validate techniques for accelerated cardiac MRI, offering better volumetric coverage of the heart, improved contrast, and superior spatial and temporal resolutions.
Interventions
- DRUG MRI Contrast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-01-01 |
| Est. Completion | 2024-01-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02550366
The ClinicalTrials.gov registry entry for NCT02550366 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI Contrast is the first listed.
NCT02550366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02550366 about?
NCT02550366 is a clinical study titled "Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI". Coronary artery disease (CAD) is the leading cause of death in the United States. Cardiac MRI is a non-invasive non-ionizing technique for a comprehensive cardiac exam, which can be used in the diagnosis of CAD. In this work, the investigators will develop and validate techniques for accelerated car...
What is the current status of trial NCT02550366?
This trial is currently terminated. The enrollment target is 44 participants. The study started on 2016-01-01. Estimated completion is 2024-01-19.
What interventions are being tested in trial NCT02550366?
The interventions under investigation include: MRI Contrast (DRUG).
Who is sponsoring clinical trial NCT02550366?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.